USPTO serial 97916527
CYAPLEX
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- FLOWERS, JAY K
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CYAPLEX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Gyeonggi-do, KR
Gyeonggi-do, KR
Gyeonggi-do, KR
Gyeonggi-do, KR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
James C. Watson
James C. Watson TRASKBRITT, P.C.230 SOUTH 500 EAST, #300SALT LAKE CITY, UT 84102United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Lactose for pharmaceutical purposes; powdered milk for babies; nutraceutical preparations for use as dietary supplements mainly based on grains extracts; nutraceutical preparations for use as dietary supplements mainly based on egg; nutraceutical preparations for use as dietary supplements mainly based on beans; nutraceutical preparations for use as dietary supplements mainly based on tofu; nutraceutical preparations for use as dietary supplements mainly based on fish extracts; nutraceutical preparations for use as dietary supplements mainly based on fish and shellfish; nutraceutical preparations for use as dietary supplements mainly based on meat; nutraceutical preparations for use as dietary supplements mainly based on vegetables; dietary supplements consisting of amino acids, minerals and trace elements; dietetic foods and beverages adapted for medical use; medicated food supplements; pharmaceutical drugs for anti-oxidant purposes; medicines for human purposes for anti-oxidant purposes; nutraceutical preparations in the nature of dietary supplements for therapeutic or medical purposes; calcium supplements; probiotic supplements; nutritional supplements consisting primarily of zinc; zinc dietary supplements; nutraceutical preparations for use as dietary supplements consisting primarily of vitamin C; nutraceutical preparations for use as dietary supplements consisting primarily of selenium; nutraceutical preparations for use as dietary supplements mainly based on hibiscus extract; nutraceutical preparations for use as dietary supplements mainly based on soybean extract; nutraceutical preparations for use as dietary supplements consisting primarily of zinc; syrups for making meal replacement beverages adapted for medical use; | ACTIVE | — |
| 029 | Processed, edible seaweed; Processed algae for human consumption; health supplement food mainly based on seaweed, namely, seaweed for use as ingredients of nutritional supplements and vitamins; health supplement food mainly based on seaweed extracts, namely, seaweed extracts for use as ingredients of nutritional supplements and vitamins; health supplement food mainly based on algae, namely, algae for use as ingredients of nutritional supplements and vitamins; health supplement food mainly based on algae extracts, namely, algae extracts for use as ingredients of nutritional supplements and vitamins; health supplement food consisting primarily of alginic acid extracted from algae, namely, alginic acid for use as ingredients of nutritional supplements and vitamins; health supplement food consisting primarily of fucoidan extracted from algae, namely, fucoidan for use as ingredients of nutritional supplements and vitamins; Processed fruit; Processed vegetables; health supplement food mainly based on fruits extracts, namely, fruits extracts for use as ingredients of nutritional supplements and vitamins; health supplement food mainly based on fruits, namely, processed fruits for use as ingredients of nutritional supplements and vitamins; health supplement food mainly based on aronia, namely, aronia for use as ingredients of nutritional supplements and vitamins; health supplement food mainly based on aronia extracts, namely, aronia extracts for use as ingredients of nutritional supplements and vitamins; health supplement food mainly based on vegetable extracts, namely, vegetable extracts for use as ingredients of nutritional supplements and vitamins; health supplement food mainly based on vegetables, namely, processed vegetables for use as ingredients of nutritional supplements and vitamins; health supplement food consisting primarily of anthocyanin extracted from fruits, namely, anthocyanin extracts for use as ingredients of nutritional supplements and vitamins; health supplement food consisting primarily of cyanidin extracted from fruits, namely, cyanidin extracts for use as ingredients of nutritional supplements and vitamins | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BONG KEUN JANG
- Other trademarks owned by BONG KEUN JANG
- Other trademarks owned by JBKLAB Co.,Ltd.
- Other trademarks owned by JBKLAB Co.,Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 029
- Similar marks named CYAPLEX
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 19, 2026 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Feb 19, 2026 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 21, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 20, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| May 12, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 11, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| Apr 14, 2025 | NOAC | CORRECTED NOA E-MAILED | — |
| Apr 11, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 10, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 10, 2025 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Mar 2, 2025 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 4, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 4, 2024 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Dec 4, 2024 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Dec 4, 2024 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Dec 4, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 4, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 9, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 9, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 20, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 29, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 28, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 28, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 28, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 28, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 2, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 2, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 2, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 29, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| May 31, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 5, 2023 | NWAP | NEW APPLICATION ENTERED | — |